CELLID CO., LTD.
Diupdate

Cellid, COVID-19 vaccine Korean stock

152
Bullish

Reasons
- Cup & handle formation
- Bounces on trendline
- Currently developing COVID-19 vaccine in Korea alongside other biotech products
- Korean government granted $30 mil to develop vaccines recently
Trade aktif
Prices pulled back from the initial trendline due to choppiness from falling KOSDAQ index. This was due to fears of economic shutdown from COVID-19 breakouts.

Still a go. It still has not announced a clinical trial for the COVID-19 vaccine but received money from the Korean government to develop one. If it is announced, then it is going to rocket.
Trade aktif
Space elevator~
Trading ditutup: stop tercapai
Events didn't pan out as I had expected.

Too bad.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.